Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Clinical trial NCT00448357 · COMPLETED

Trial details

NCT number: NCT00448357
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes

Start date: 2005-10-01
Primary completion: 2015-11-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.